Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05815628

Next-Generation-Sequencing Approach to Neutropenic Sepsis

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Boris Böll · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.

Detailed description

The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER (Platform for digital pathogen diagnostics from Noscendo GmbH) in neutropenic patients with FN (Febrile neutropenia) is to provide further evidence of the efficacy of an NGS (Next-generation seqzencing)-based approach for detecting bloodstream infection in neutropenic patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDISQVERNGS based infection diagnosis

Timeline

Start date
2024-06-05
Primary completion
2026-09-30
Completion
2026-11-01
First posted
2023-04-18
Last updated
2025-08-08

Locations

6 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT05815628. Inclusion in this directory is not an endorsement.

Next-Generation-Sequencing Approach to Neutropenic Sepsis (NCT05815628) · Clinical Trials Directory